Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02 - Related Studies

Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02 (TEXT-Bone)

This study is ongoing, but not recruiting participants.

Study NCT00963417 Information provided by International Breast Cancer Study Group

First Received on August 20, 2009. Last Updated on April 3, 2013 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Breast Cancer
Osteoporosis

Additional conditions recognized in this trial

Breast Neoplasms

More general conditions related to this trial

Interventions listed in this trial

Additional drug interventions recognized in this trial

Exemestane
Tamoxifen
Triptorelin

More general drug interventions related to this trial

Sponsors listed in this trial